Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (81-90 of 403) with videos related to

Pageof 41
Sort By:
BMC Medicine|April 23, 2020
Transmissibility and pathogenicity of the emerging meningococcal serogroup W sequence type-11 complex South American strain: a mathematical modeling studyMatthieu Domenech de Cellès, Helen Campbell, Ray Borrow, et al.
Expert Review of Vaccines|December 11, 2014
Evolving meningococcal immunization strategiesMarco Aurélio Sáfadi, Julie A Bettinger, Gabriela Moreno Maturana, et al.
Vaccine|September 25, 2003
Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccineAlexander E Platonov, Irina V Vershinina, Edward J Kuijper, et al.
Vaccine|April 17, 2013
An overview of meningococcal disease in India: knowledge gaps and potential solutionsT Jacob John, Sunil Gupta, A J Chitkara, et al.
Human Vaccines & Immunotherapeutics|April 3, 2020
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized studyTimo Vesikari, Ray Borrow, Aino Forsten, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2015
Reply to MusherNicholas Brousseau, Mary P E Slack, Pauline Waight, et al.
Vaccine|November 8, 2015
Response to pneumococcal polysaccharide vaccination in patients with chronic and allergic aspergillosisChris Kosmidis, Georgina Powell, Ray Borrow, et al.
The Journal of Infectious Diseases|November 17, 2006
Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United KingdomCressida Auckland, Stephen Gray, Ray Borrow, et al.
Clinical and Diagnostic Laboratory Immunology|January 13, 2004
Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi ArabiaHani Jokhdar, Ray Borrow, Abdulrazaq Sultan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Evidence for naturally acquired T cell-mediated mucosal immunity to Neisseria meningitidisVictoria Davenport, Terry Guthrie, Jamie Findlow, et al.
Pageof 41

Showing results (81-90 of 403) with videos related to

Sort By:
Pageof 41
BMC Medicine|April 23, 2020
Transmissibility and pathogenicity of the emerging meningococcal serogroup W sequence type-11 complex South American strain: a mathematical modeling studyMatthieu Domenech de Cellès, Helen Campbell, Ray Borrow, et al.
Expert Review of Vaccines|December 11, 2014
Evolving meningococcal immunization strategiesMarco Aurélio Sáfadi, Julie A Bettinger, Gabriela Moreno Maturana, et al.
Vaccine|September 25, 2003
Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccineAlexander E Platonov, Irina V Vershinina, Edward J Kuijper, et al.
Vaccine|April 17, 2013
An overview of meningococcal disease in India: knowledge gaps and potential solutionsT Jacob John, Sunil Gupta, A J Chitkara, et al.
Human Vaccines & Immunotherapeutics|April 3, 2020
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized studyTimo Vesikari, Ray Borrow, Aino Forsten, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2015
Reply to MusherNicholas Brousseau, Mary P E Slack, Pauline Waight, et al.
Vaccine|November 8, 2015
Response to pneumococcal polysaccharide vaccination in patients with chronic and allergic aspergillosisChris Kosmidis, Georgina Powell, Ray Borrow, et al.
The Journal of Infectious Diseases|November 17, 2006
Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United KingdomCressida Auckland, Stephen Gray, Ray Borrow, et al.
Clinical and Diagnostic Laboratory Immunology|January 13, 2004
Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi ArabiaHani Jokhdar, Ray Borrow, Abdulrazaq Sultan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Evidence for naturally acquired T cell-mediated mucosal immunity to Neisseria meningitidisVictoria Davenport, Terry Guthrie, Jamie Findlow, et al.
Pageof 41